ARCUTIS BIOTHERAPEUTICS INC's ticker is and the CUSIP is 03969K908. A total of 3 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,860 | +568.6% | 6,000 | +1100.0% | 0.00% | – |
Q2 2023 | $4,765 | -97.9% | 500 | -97.5% | 0.00% | -100.0% |
Q1 2023 | $223,300 | -86.5% | 20,300 | -81.8% | 0.00% | -75.0% |
Q4 2022 | $1,650,200 | -3.4% | 111,500 | +24.7% | 0.00% | +33.3% |
Q3 2022 | $1,708,000 | +1776.9% | 89,400 | +1802.1% | 0.00% | – |
Q1 2022 | $91,000 | – | 4,700 | -85.4% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 32,200 | +2583.3% | 0.00% | – |
Q2 2021 | $33,000 | -70.8% | 1,200 | -69.2% | 0.00% | – |
Q1 2021 | $113,000 | – | 3,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 6,000 | $31,860 | 0.00% |
SIMPLEX TRADING, LLC | 5,700 | $30 | 0.00% |